CD274 and ovarian carcinoma: The second and third most-cited articles are by Julie R. Brahmer, titled “Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer (23)“(citation burst = 15.89), and by Wei-Ting Hwang, titled “Prognostic Significance of Tumor-Infiltrating T Cells in Ovarian Cancer: A Meta-Analysis” (citation burst = 15.89).